Bausch + Lomb Corporation announced on May 19, 2025, that its majority shareholder, Bausch Health Companies Inc. (BHC), has entered into separate letter agreements with key shareholder groups, including the Icahn Group, the Paulson Group, and the Kavanagh Group. These agreements stipulate that if any group engages in specific actions, such as supporting proxy contests or acquiring significant shares, they must immediately resign from the boards of both BHC and Bausch + Lomb. Additionally, the Icahn Group has waived certain rights related to director appointments. While Bausch + Lomb is not a direct party to these agreements, BHC has committed to supporting management nominees from these groups, provided they refrain from engaging in specified actions. This announcement was detailed in BHC's Form 8-K filed on May 21, 2025.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。